319
Views
16
CrossRef citations to date
0
Altmetric
Hematological Malignancy: Lymphoma

Alterations in the expression pattern of TCR ζ chain in T cells from patients with hematological diseases

Pages 267-275 | Published online: 18 Jul 2013

References

  • Weissman AM, Samelson LE, Klausner RD. A new subunit of the human T-cell antigen receptor complex. Nature 1986; 324: 480–482.
  • Samelson LE, Harford JB, Klausner RD. Identification of the components of the murine T cell antigen receptor complex. Cell 1985; 43: 223–231.
  • Ciszak L, Pawlak E, Kosmaczewska A, Potoczek S, Frydecka I. Alterations in the expression of signal-transducing CD3 zeta chain in T cells from patients with chronic inflammatory/autoimmune diseases. Arch Immunol Ther Exp (Warsz) 2007; 55: 373–586.
  • Li Y. Leukemia associated clonal expansion TCR WI subfamily Tcells. Hematology 2003; 8: 375–384.
  • Li Y, Chen S, Yang L et al. Clonal expanded TCR Vf T cells inpatients with APL. Hematology 2005; 10: 135–139.
  • Chen X, Woiciechowsky A, Raffegerst S, Schendel D, Kolb Hi, Roskrow M. Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis. Br J Haematol 2000; 111: 817–825.
  • Solomou EE, Wong S, Visconte V, Gibellini F, Young NS. Decreased TCR zeta-chain expression in T cells from patients with acquired aplastic anaemia. Br J Haematol 2007; 138: 72–76.
  • Torelli GF, Paolini R, Tatarelli C et al. Defective expression of theT-cell receptor-CD3 zeta chain in T-cell acute lymphoblastic leukaemia. Br J Haematol 2003; 120: 201–208.
  • Weissman AM, Hou D, Orloff DG et al. Molecular cloning andchromosomal localization of the human T-cell receptor zeta chain: distinction from the molecular CD3 complex. Proc Natl Acad Sci USA 1988; 85: 9709–9713.
  • Baniyash M, Hsu VW, Seldin MF, Klausner RD. The isolation and characterization of the murine T cell antigen receptor zeta chain gene. J Biol Chem 1989; 264: 13252–13257.
  • Jensen JP, Hou D, Ramsburg M, Taylor A, Dean M, Weissman AM. Organization of the human T cell receptor zeta/eta gene and its genetic linkage to the Fc gamma RII-Fc gamma RIII gene cluster. J Immunol 1992; 148: 2563–2571.
  • Pitcher LA, Mathis MA, Subramanian S et al. Selective expression of the 21-kilodalton tyrosine-phosphorylated form of TCR zeta promotes the emergence of T cells with autoreactive potential. J Immunol 2005; 174: 6071–6079.
  • Pitcher LA, Young JA, Mathis MA, Wrage PC, Bartók B, van Oers NS. The formation and functions of the 21- and 23-kDa tyrosine-phosphorylated TCR zeta subunits. Immunol Rev 2003; 191: 47–61.
  • Samelson LE, Davidson WF, Morse HCIII, Klausner RD. Abnormal tyrosine phosphorylation on T-cell receptor in lympho-proliferative disorders. Nature 1986; 324: 674–676.
  • Pitcher LA, van Oers NS. T-cell receptor signal transmission: who gives an ITAM? Trends Immunol 2003; 24: 554–560.
  • Chitu V, Fajka-Boja R, Tóth GKMorse HCIII, Klausner RD. Abnormal tyrosine phosphorylation on T-cell receptor in lympho-proliferative disorders. Comparative study on the effect of phosphorylated TCR zeta chain ITAM sequences on early activation events in Jurkat T cells. Peptides 2001; 22: 1963–1971.
  • Shores EW, Love PE. TCR zeta chain in T cell development and selection. Curr Opin Immunol 1997; 9: 380–389.
  • Wiest DL, Kearse KP, Shores EW, Singer A. Developmentally regulated expression of CD3 components independent of clono-typic T cell antigen receptor complexes on immature thymocytes. J Exp Med 1994; 180: 1375–1382.
  • Crompton T, Moore M, MacDonald HR, Malissen B. Double-negative thymocyte subsets in CD3 zeta chain-deficient mice: absence of HSA+ CD44-CD25- cells. Eur J Immunol 1994; 24: 1903–1907.
  • van Oers NS, von Boehmer H, Weiss A. The pre-T cell receptor (TCR) complex is functionally coupled to the TCR-zeta subunit. J Exp Med 1995; 182: 1585–1590.
  • Shores EW, Huang K, Tran T, Lee E, Grinberg A, Love PE. Role of TCR zeta chain in T cell development and selection. Science 1994; 266: 1047–1050.
  • Simpson S, Holländer G, She J, Levelt C, Huang M, Terhorst C. Selection of peripheral and intestinal T lymphocytes lacking CD3 zeta. Int Immunol 1995; 7: 287–293.
  • Shores EW, Tran T, Grinberg A, Sommers CL, Shen H, Love PE. Role of the multiple T cell receptor (TCR)-zeta chain signaling motifs in selection of the T cell repertoire. J Exp Med 1997; 185: 893–900.
  • Love PE, Lee J, Shores EW. Critical relationship between TCR signaling potential and TCR affinity during thymocyte selection. J Immunol 2000; 165: 3080–3087.
  • Minguet S, Swamy M, Dopfer EP, Dengler E, Alarcon B, Schamel WW. The extracellular part of zeta is buried in the T cell antigen receptor complex. Immunol Lett 2008; 116: 203–210.
  • Minguet S, Swamy M, Schamel WW. The short length of the extracellular domain of zeta is crucial for T cell antigen receptor function. Immunol Lett 2008; 116: 195–202.
  • Weissman AM, Baniyash M, Hou D, Samelson LE, Burgess WH, Klausner RD. Molecular cloning of the zeta chain of the T cell antigen receptor. Science 1988; 239: 1018–1021.
  • Stacey M, Barlow A, Hulten M. Human T-cell receptor zeta chain gene Map position 1q23.1. Chromosome Res 1997; 5: 279.
  • Nambiar MP, Enyedy EJ, Warke VG et al. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA. Arthritis Rheum 2001; 44: 1336–1350.
  • Frank Si, Niklinska BB, Orloff DG, Meréep M, Ashwell JD, Klausner RD. Structural mutations of the T cell receptor zeta chain and its role in T cell activation. Science 1990; 249: 174–177.
  • Wu J, Edberg JC, Gibson AW, Tsao B, Kimberly RP. Single-nucleotide polymorphisms of T cell receptor zeta chain in patients with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 2601–2605.
  • Moingeon P, Stebbins CC, D'Adamio L, Lucich J, Reinherz EL. Human natural killer cells and mature T lymphocytes express identical CD3 zeta subunits as defined by cDNA cloning and sequence analysis. Eur J Immunol 1990; 20: 1741–1745.
  • Takeuchi T, Tsuzaka K, Pang M, Amano K, Koide J, Abe T. TCR zeta chain lacking exon 7 in two patients with systemic lupus erythematosus. Int Immunol 1998; 10: 911–921.
  • Tsuzaka K, Fukuhara I, Setoyama Y et al. TCR zeta mRNA with an alternatively spliced 3'-untranslated region detected in systemic lupus erythematosus patients leads to the down-regulation of TCR zeta and TCR/CD3 complex. J Immunol 2003; 171: 2496–2503.
  • Nambiar MP, Enyedy EJ, Warke VG et al. Polymorphisms/ mutations of TCR-zeta-chain promoter and 3' untranslated region and selective expression of TCR zeta-chain with an alternatively spliced 3' untranslated region in patients with systemic lupus erythematosus. J Autoimmun 2001; 16: 133–142.
  • Atkinson TP, Hall CG, Goldsmith J, Kirkham PM. Splice variant in TCRzeta links T cell receptor signaling to a G-protein-related signaling pathway. Biochem Biophys Res Commun 2003; 310: 761–766.
  • Tsuzaka K, Setoyama Y, Yoshimoto K et al. A splice variant of the TCR zeta mRNA lacking exon 7 leads to the down-regulation of TCR zeta, the TCR/CD3 complex, and IL-2 production in systemic lupus erythematosus T cells. J Immunol 2005; 174: 3518–3525.
  • Tsuzaka K, Nozaki K, Kumazawa C et al. DNA microarray gene expression profile of T cells with the splice variants of TCRzeta mRNA observed in sy stemic lupus erythematosus. J Immunol 2006; 176: 949–956.
  • Tsuzaka K, Itami Y, Kumazawa C et al. Conservative sequences in 3'UTR of TCRzeta mRNA regulate TCRzeta in SLE T cells. Biochem Biophys Res Commun 2008; 367: 311–317.
  • Mizoguchi H, O'Shea ii, Longo DL, Loeffler CM, McVicar DW, Ochoa AC. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 1992; 258: 1795–1798.
  • Lai P, Rabinowich H, Crowley-Nowick PA, Bell MC, Mantovani G, Whiteside TL. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. Clin Cancer Res 1996; 2: 161–173.
  • Zea AH, Curti BD, Longo DL et al. Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin Cancer Res 1995; 1: 1327–1335.
  • Finke JH, Rayman P, Hart L et al. Characterization of tumor-infiltrating lymphocyte subsets from human renal cell carcinoma: specific reactivity defined by cytotoxicity, interferon-gamma secretion, and proliferation. J Immunother Emphasis Tumor Immunol 1994; 15: 91–104.
  • Kuss I, Saito T, Johnson JT, Whiteside TL. Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer. Clin Cancer Res 1999; 5:329–334.
  • Yang L, Li Y, Li C, Chen S, Chen S, Lin C. Expression pattern of TCR-zeta chain in patients with aplastic anemia and polycythemia vera. Blood 2007; 110: 7B.
  • Zhang X, Li Y, Chen Set al. The feature of TCR WI repertoire, thymicrecent output function and TCR-zeta chain expression in patients with immune thrombocytopenic purpura. Blood 2007; 110: 625A.
  • Suzushima H, Hattori T, Asou N et al. Discordant gene and surface expression of the T-cell receptor/CD3 complex in adult T-cell leukemia cells. Cancer Res 1991; 51: 6084–6088.
  • de Waal Malefyt R, Yssel H, Spits H et al. Human T cell leukemia virus type I prevents cell surface expression of the T cell receptor through down-regulation of the CD3-gamma, -delta, -epsilon, and -zeta genes. J Immunol 1990; 145: 2297–2303.
  • Vitale B, Martinis M, Antica M et al. Prolegomenon for chronic lymphocytic leukaemia. Scand J Immunol 2003; 58: 588–600.
  • Kiaii S, Choudhury A, Mozaffari F, Kimby E, Osterborg A, Mellstedt H. Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia (B-CLL): comparison of indolent and progressive disease. Med Oncol 2005; 22: 291–302.
  • Buggins AG, Hirst WJ, Pagliuca A, Mufti GJ. Variable expression of CD3-zeta and associated protein tyrosine kinases in lympho-cytes from patients with myeloid malignancies. Br J Haematol 1998; 100: 784–792.
  • Chen S, Li Y, Chen S, Yang L, Wu X, Cen D. The feature of TCR zeta gene in CD4 + and CD8 + T cells in patients with CML. Blood 2007; 110: 203B.
  • Slivnick DJ, Ellis TM, Nawrocki JF, Fisher RI. The impact of Hodgkin's disease on the immune system. Semin Oncol 1990; 17: 673–782.
  • Bonzheim I, Geissinger E, Roth S et al. Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling. Blood 2004; 104: 3358–3360.
  • Wang Q, Stanley J, Kudoh S et al. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphoryla-tion pattern even though T cell receptor/CD3-associated kinases are present. J Immunol 1995; 155: 1382–1392.
  • Renner C, Ohnesorge S, Held G et al. T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28. Blood 1996; 88: 236–241.
  • Dukers DF, Oudejans ii, Jaspars EH et al. All infiltrating T-lymphocytes in Hodgkin's disease express immunohistochemically detectable T-cell receptor zeta-chains in situ. Histopathology 2000; 36: 544–550.
  • Kono K, Salazar-Onfray F, Petersson M et al. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity. Eur J Immunol 1996; 26: 1308–1313.
  • Hirst W, Buggins A, Mufti G. Central role of leukemia-derived factors in the development of leukemia-associated immune dysfunction. Hematol J 2001; 2: 2–17.
  • Nambiar MP, Enyedy EJ, Fisher CU, Warke VG, Juang YT, Tsokos GC. Dexamethasone modulates TCR zeta chain expression and antigen receptor-mediated early signaling events in human T lymphocytes. Cell Immunol 2001; 208: 62–71.
  • Wang L, Bronstein N, Hsu V, Baniyash M. Transcriptional regulation of the murine TCR zeta gene. Int Immunol 1995; 7: 1627–1635.
  • Stamatopoulos B, Meuleman N, Haibe-Kains B et al. Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia. Clin Chem 2007; 53: 1757–1766.
  • Whiteside TL. Down-regulation of zeta-chain expression in T cells:a biomarker of prognosis in cancer? Cancer Immunol Immunother 2004; 53: 865–878.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.